Urszula Sowa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Urszula Sowa has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
- Jan Swakoń
Institute of Nuclear Physics, Polish Academy of Sciences, Radzikowski Street 152, 31-342 Krakow, Poland
7 shared publications - Barbara Michalec
Institute of Nuclear Physics Polish Academy of Sciences , Radzikowskiego 152, 31-342 Krakow, Poland
5 shared publications - Pawel Olko
Institute of Nuclear Physics Polish Academy of Sciences, Krakow, Poland
5 shared publications Marta Ptaszkiewicz
4 shared publications- Tomasz Horwacik
Institute of Nuclear Physics, Polish Academy of Sciences, PL-31342 Kraków, Poland
3 shared publications - Jan Gajewski
Institute of Nuclear Physics PAN, Kraków, Poland
2 shared publications
Latest Publications
- Open Access
Application of the Deep Inspiration Breath-Hold Technique in Proton Therapy for Mediastinal Lymphomas: Initial Experience
Background: This work presents the procedures and application of the deep inspiration breath-hold (DIBH) technique for mediastinal lymphoma patients at a proton therapy (PT) center. It also discusses the implementation and validation of the surface-guided radiotherapy (SGRT) protocol in terms of positioning accuracy. Methods: This study included six lymphoma patients. Dedicated computed tomography (CT) protocols and a treatment workflow based on international guidelines were developed. Clinical data from the treatment planning system (TPS) were used to assess the difference between DIBH and free-breathing irradiation. Additionally, data from an optical patient positioning system and kilovoltage (kV) imaging system were used to estimate positioning shifts. The new CT protocol reduced the volume CT dose index by over six times compared with the standard protocol. Results: The DIBH method decreased the mean dose to the heart and lungs by up to 7.02 Gy(RBE) and 0.83 Gy(RBE), respectively. The median magnitude of patient setup errors and repeatability in DIBH positioning was 0.4 cm and 0.18 cm (mean for males and females) for the SGRT protocol. The kV imaging showed a setup error of over 0.3 cm for both groups. Conclusions: Despite the small size of the patient cohort, the relatively large number of individual positioning sessions enabled the detection of statistically significant differences (p < 0.05) in certain areas between male and female patients; however, no significant difference in the displacement vector magnitude was observed. DIBH treatment with SGRT offers high reproducibility for patient positioning.
Open AccessApplication of the Deep Inspiration Breath-Hold Technique in Proton Therapy for Mediastinal Lymphomas: Initial Experience
Background: This work presents the procedures and application of the deep inspiration breath-hold (DIBH) technique for mediastinal lymphoma patients at a proton therapy (PT) center. It also discusses the implementation and validation of the surface-guided radiotherapy (SGRT) protocol in terms of positioning accuracy. Methods: This study included six lymphoma patients. Dedicated computed tomography (CT) protocols and a treatment workflow based on international guidelines were developed. Clinical data from the treatment planning system (TPS) were used to assess the difference between DIBH and free-breathing irradiation. Additionally, data from an optical patient positioning system and kilovoltage (kV) imaging system were used to estimate positioning shifts. The new CT protocol reduced the volume CT dose index by over six times compared with the standard protocol. Results: The DIBH method decreased the mean dose to the heart and lungs by up to 7.02 Gy(RBE) and 0.83 Gy(RBE), respectively. The median magnitude of patient setup errors and repeatability in DIBH positioning was 0.4 cm and 0.18 cm (mean for males and females) for the SGRT protocol. The kV imaging showed a setup error of over 0.3 cm for both groups. Conclusions: Despite the small size of the patient cohort, the relatively large number of individual positioning sessions enabled the detection of statistically significant differences (p < 0.05) in certain areas between male and female patients; however, no significant difference in the displacement vector magnitude was observed. DIBH treatment with SGRT offers high reproducibility for patient positioning.
- Open Access
3D Dosimetry Based on LiMgPO4 OSL Silicone Foils: Facilitating the Verification of Eye-Ball Cancer Proton Radiotherapy
A direct verification of the three-dimensional (3D) proton clinical treatment plan prepared for tumor in the eyeball, using the Eclipse Ocular Proton Planning system (by Varian Medical Systems), has been presented. To achieve this, a prototype of the innovative two-dimensional (2D) circular silicone foils, made of a polymer with the embedded optically stimulated luminescence (OSL) material in powder form (LiMgPO4), and a self-developed optical imaging system, consisting of an illuminating light source and a high-sensitive CCD camera has been applied. A specially designed lifelike eyeball phantom has been used, constructed from 40 flat sheet LMP-based silicone foils stacked and placed together behind a spherical phantom made by polystyrene, all to reflect the curvature of the real eyeball. Two-dimensional OSL signals were captured and further analyzed from each single silicone foil after irradiation using a dedicated patient collimator and a 58.8 MeV modulated proton beam. The reconstructed 3D proton depth dose distribution matches very well with the clinical treatment plan, allowing for the consideration of the new OSL system for further 3D dosimetry applications within the proton radiotherapy area.
Open Access3D Dosimetry Based on LiMgPO4 OSL Silicone Foils: Facilitating the Verification of Eye-Ball Cancer Proton Radiotherapy
A direct verification of the three-dimensional (3D) proton clinical treatment plan prepared for tumor in the eyeball, using the Eclipse Ocular Proton Planning system (by Varian Medical Systems), has been presented. To achieve this, a prototype of the innovative two-dimensional (2D) circular silicone foils, made of a polymer with the embedded optically stimulated luminescence (OSL) material in powder form (LiMgPO4), and a self-developed optical imaging system, consisting of an illuminating light source and a high-sensitive CCD camera has been applied. A specially designed lifelike eyeball phantom has been used, constructed from 40 flat sheet LMP-based silicone foils stacked and placed together behind a spherical phantom made by polystyrene, all to reflect the curvature of the real eyeball. Two-dimensional OSL signals were captured and further analyzed from each single silicone foil after irradiation using a dedicated patient collimator and a 58.8 MeV modulated proton beam. The reconstructed 3D proton depth dose distribution matches very well with the clinical treatment plan, allowing for the consideration of the new OSL system for further 3D dosimetry applications within the proton radiotherapy area.
- Open Access
- 19 July 2014
- Published by Springer Nature in Radiation and Environmental Biophysics
- Vol. 53 (4) , 745-754
Relative biological effectiveness of the 60-MeV therapeutic proton beam at the Institute of Nuclear Physics (IFJ PAN) in Kraków, Poland
The aim of the study was to determine the relative biological effectiveness (RBE) of a 60-MeV proton radiotherapy beam at the Institute of Nuclear Physics, Polish Academy of Sciences (IFJ PAN) in Kraków, the first one to operate in Poland. RBE was assessed at the surviving fractions (SFs) of 0.01, 0.1, and 0.37, for normal human fibroblasts from three cancer patients. The cells were irradiated near the Bragg peak of the pristine beam and at three depths within a 28.4-mm spread-out Bragg peak (SOBP). Reference radiation was provided by 6-MV X-rays. The mean RBE value at SF = 0.01 for fibroblasts irradiated near the Bragg peak of pristine beam ranged between 1.06 and 1.15. The mean RBE values at SF = 0.01 for these cells exposed at depths of 2, 15, and 27 mm of the SOBP ranged between 0.95–1.00, 0.97–1.02, and 1.05–1.11, respectively. A trend was observed for RBE values to increase with survival level and with depth in the SOBP: at SF = 0.37 and at the depth of 27 mm, RBE values attained their maximum (1.19–1.24). The RBE values estimated at SF = 0.01 using normal human fibroblasts for the 60-MeV proton radiotherapy beam at the IFJ PAN in Kraków are close to values of 1.0 and 1.1, used in clinical practice.
- 19 July 2014
- Published by Springer Nature in Radiation and Environmental Biophysics
- Vol. 53 (4) , 745-754
Open AccessRelative biological effectiveness of the 60-MeV therapeutic proton beam at the Institute of Nuclear Physics (IFJ PAN) in Kraków, Poland
The aim of the study was to determine the relative biological effectiveness (RBE) of a 60-MeV proton radiotherapy beam at the Institute of Nuclear Physics, Polish Academy of Sciences (IFJ PAN) in Kraków, the first one to operate in Poland. RBE was assessed at the surviving fractions (SFs) of 0.01, 0.1, and 0.37, for normal human fibroblasts from three cancer patients. The cells were irradiated near the Bragg peak of the pristine beam and at three depths within a 28.4-mm spread-out Bragg peak (SOBP). Reference radiation was provided by 6-MV X-rays. The mean RBE value at SF = 0.01 for fibroblasts irradiated near the Bragg peak of pristine beam ranged between 1.06 and 1.15. The mean RBE values at SF = 0.01 for these cells exposed at depths of 2, 15, and 27 mm of the SOBP ranged between 0.95–1.00, 0.97–1.02, and 1.05–1.11, respectively. A trend was observed for RBE values to increase with survival level and with depth in the SOBP: at SF = 0.37 and at the depth of 27 mm, RBE values attained their maximum (1.19–1.24). The RBE values estimated at SF = 0.01 using normal human fibroblasts for the 60-MeV proton radiotherapy beam at the IFJ PAN in Kraków are close to values of 1.0 and 1.1, used in clinical practice.
- 29 May 2014
- Published by Oxford University Press (OUP) in Radiation Protection Dosimetry
- Vol. 159 (1-4) , 137-140
Applicability of EPR/alanine dosimetry for quality assurance in proton eye radiotherapy
A new quality assurance and quality control method for proton eye radiotherapy based on electron paramagnetic resonance (EPR)/alanine dosimetry has been developed. It is based on Spread-Out Bragg Peak entrance dose measurement with alanine detectors. The entrance dose is well correlated with the dose at the facility isocenter, where, during the therapeutic irradiation, the tumour is placed. The unique alanine detector features namely keeping the dose record in a form of stable radiation-induced free radicals trapped in the material structure, and the non-destructive read-out makes this type of detector a good candidate for additional documentation of the patient's exposure over the therapy course.
- 29 May 2014
- Published by Oxford University Press (OUP) in Radiation Protection Dosimetry
- Vol. 159 (1-4) , 137-140
Applicability of EPR/alanine dosimetry for quality assurance in proton eye radiotherapy
A new quality assurance and quality control method for proton eye radiotherapy based on electron paramagnetic resonance (EPR)/alanine dosimetry has been developed. It is based on Spread-Out Bragg Peak entrance dose measurement with alanine detectors. The entrance dose is well correlated with the dose at the facility isocenter, where, during the therapeutic irradiation, the tumour is placed. The unique alanine detector features namely keeping the dose record in a form of stable radiation-induced free radicals trapped in the material structure, and the non-destructive read-out makes this type of detector a good candidate for additional documentation of the patient's exposure over the therapy course.
- Open Access
- 2 January 2014
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (1) , e84621
Proteomic Analysis of Proton Beam Irradiated Human Melanoma Cells
Proton beam irradiation is a form of advanced radiotherapy providing superior distributions of a low LET radiation dose relative to that of photon therapy for the treatment of cancer. Even though this clinical treatment has been developing for several decades, the proton radiobiology critical to the optimization of proton radiotherapy is far from being understood. Proteomic changes were analyzed in human melanoma cells treated with a sublethal dose (3 Gy) of proton beam irradiation. The results were compared with untreated cells. Two-dimensional electrophoresis was performed with mass spectrometry to identify the proteins. At the dose of 3 Gy a minimal slowdown in proliferation rate was seen, as well as some DNA damage. After allowing time for damage repair, the proteomic analysis was performed. In total 17 protein levels were found to significantly (more than 1.5 times) change: 4 downregulated and 13 upregulated. Functionally, they represent four categories: (i) DNA repair and RNA regulation (VCP, MVP, STRAP, FAB-2, Lamine A/C, GAPDH), (ii) cell survival and stress response (STRAP, MCM7, Annexin 7, MVP, Caprin-1, PDCD6, VCP, HSP70), (iii) cell metabolism (TIM, GAPDH, VCP), and (iv) cytoskeleton and motility (Moesin, Actinin 4, FAB-2, Vimentin, Annexin 7, Lamine A/C, Lamine B). A substantial decrease (2.3 x) was seen in the level of vimentin, a marker of epithelial to mesenchymal transition and the metastatic properties of melanoma.
- 2 January 2014
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (1) , e84621
Open AccessProteomic Analysis of Proton Beam Irradiated Human Melanoma Cells
Proton beam irradiation is a form of advanced radiotherapy providing superior distributions of a low LET radiation dose relative to that of photon therapy for the treatment of cancer. Even though this clinical treatment has been developing for several decades, the proton radiobiology critical to the optimization of proton radiotherapy is far from being understood. Proteomic changes were analyzed in human melanoma cells treated with a sublethal dose (3 Gy) of proton beam irradiation. The results were compared with untreated cells. Two-dimensional electrophoresis was performed with mass spectrometry to identify the proteins. At the dose of 3 Gy a minimal slowdown in proliferation rate was seen, as well as some DNA damage. After allowing time for damage repair, the proteomic analysis was performed. In total 17 protein levels were found to significantly (more than 1.5 times) change: 4 downregulated and 13 upregulated. Functionally, they represent four categories: (i) DNA repair and RNA regulation (VCP, MVP, STRAP, FAB-2, Lamine A/C, GAPDH), (ii) cell survival and stress response (STRAP, MCM7, Annexin 7, MVP, Caprin-1, PDCD6, VCP, HSP70), (iii) cell metabolism (TIM, GAPDH, VCP), and (iv) cytoskeleton and motility (Moesin, Actinin 4, FAB-2, Vimentin, Annexin 7, Lamine A/C, Lamine B). A substantial decrease (2.3 x) was seen in the level of vimentin, a marker of epithelial to mesenchymal transition and the metastatic properties of melanoma.
- 1 December 2010
- Published by Elsevier in Radiation Measurements
- Vol. 45 (10) , 1469-1471
Facility for proton radiotherapy of eye cancer at IFJ PAN in Krakow
- 1 December 2010
- Published by Elsevier in Radiation Measurements
- Vol. 45 (10) , 1469-1471
Facility for proton radiotherapy of eye cancer at IFJ PAN in Krakow
- 1 April 2010
- Published by Elsevier in Applied Radiation and Isotopes
- Vol. 68 (4-5) , 738-742
Proton radiotherapy facility for ocular tumors at the IFJ PAN in Kraków Poland
- 1 April 2010
- Published by Elsevier in Applied Radiation and Isotopes
- Vol. 68 (4-5) , 738-742
Proton radiotherapy facility for ocular tumors at the IFJ PAN in Kraków Poland
- 1 October 2008
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1073-1076
Optimization of Beam Scattering System for IFJ PAN Proton Radiotherapy Facility by Monte Carlo Simulations
The work is aimed at optimizing the 60 MeV proton beam spreading system at the IFJ PAN radiotherapy facility for the treatment of ocular melanoma tumors. Single scattering foil and double scattering foil systems have been investigated by Monte Carlo simulations. In the case of the single scattering foil system dose distributions were uniform to within ± 1 % over a 4-cm-diameter region, whereas in the case of the double scattering foil system the same uniformity was achieved in a region up to 3.6 cm in diameter, but its efficiency of dose rates was 5.7 times better. Since the total thickness of foils in the single and the double foil systems was equivalent, in both cases the energy loss of protons was approximately the same.
- 1 October 2008
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1073-1076
Optimization of Beam Scattering System for IFJ PAN Proton Radiotherapy Facility by Monte Carlo Simulations
The work is aimed at optimizing the 60 MeV proton beam spreading system at the IFJ PAN radiotherapy facility for the treatment of ocular melanoma tumors. Single scattering foil and double scattering foil systems have been investigated by Monte Carlo simulations. In the case of the single scattering foil system dose distributions were uniform to within ± 1 % over a 4-cm-diameter region, whereas in the case of the double scattering foil system the same uniformity was achieved in a region up to 3.6 cm in diameter, but its efficiency of dose rates was 5.7 times better. Since the total thickness of foils in the single and the double foil systems was equivalent, in both cases the energy loss of protons was approximately the same.
- 1 October 2008
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- No. 10823654,p. 1093-1096
Radiation exposure at the proton eye therapy facility at IFJ in Kraków
The proton radiotherapy facility for the treatment of eye tumors is under development at the Institute of Nuclear Physics (IFJ) in Kraków. The optical line installed at the treatment room is applied to form and monitor the 60 MeV proton beam provided by the AIC-144 isochronous cyclotron. Typical proton dose rates measured at the isocentre varied between 0.01 and 0.5 Gy/s. The intensities of the secondary radiation field inside and around the treatment room have been measured with a stationary monitoring system. Four sets of radiation monitors provide the continuous monitoring of gamma and neutron radiation during the operation of the facility. Monte Carlo calculations have been performed for understanding the structure of the radiation field inside the treatment room. Typical ambient dose equivalent rates inside the treatment room vary between 100 and 800 μSv/h for neutrons and between 10 and 130 μSv/h for gamma rays. The maximum values were found to be 2.5 mSv/h and 0.3 mSv/h respectively. The ambient dose equivalent rates outside the therapy room were not higher than 2.5 μSv/h for neutrons and 0.35 μSv/h for gamma rays. The end of the beam line, the optical line and the beam scattering system are main sources of the secondary radiation. Optimisation and shielding of these elements will reduce the patient and facility personnel exposure to the secondary radiation.
- 1 October 2008
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- No. 10823654,p. 1093-1096
Radiation exposure at the proton eye therapy facility at IFJ in Kraków
The proton radiotherapy facility for the treatment of eye tumors is under development at the Institute of Nuclear Physics (IFJ) in Kraków. The optical line installed at the treatment room is applied to form and monitor the 60 MeV proton beam provided by the AIC-144 isochronous cyclotron. Typical proton dose rates measured at the isocentre varied between 0.01 and 0.5 Gy/s. The intensities of the secondary radiation field inside and around the treatment room have been measured with a stationary monitoring system. Four sets of radiation monitors provide the continuous monitoring of gamma and neutron radiation during the operation of the facility. Monte Carlo calculations have been performed for understanding the structure of the radiation field inside the treatment room. Typical ambient dose equivalent rates inside the treatment room vary between 100 and 800 μSv/h for neutrons and between 10 and 130 μSv/h for gamma rays. The maximum values were found to be 2.5 mSv/h and 0.3 mSv/h respectively. The ambient dose equivalent rates outside the therapy room were not higher than 2.5 μSv/h for neutrons and 0.35 μSv/h for gamma rays. The end of the beam line, the optical line and the beam scattering system are main sources of the secondary radiation. Optimisation and shielding of these elements will reduce the patient and facility personnel exposure to the secondary radiation.